Filing Details

Accession Number:
0001209191-15-074442
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-10-06 20:21:37
Reporting Period:
2015-10-02
Filing Date:
2015-10-06
Accepted Time:
2015-10-06 20:21:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1008848 Acorda Therapeutics Inc ACOR Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1272354 Ron Cohen 420 Saw Mill River Road
Ardsley NY 10502
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-10-02 8,811 $6.00 421,211 No 4 M Direct
Common Stock Acquisiton 2015-10-02 70,358 $5.85 491,569 No 4 M Direct
Common Stock Acquisiton 2015-10-02 500 $8.50 492,069 No 4 M Direct
Common Stock Acquisiton 2015-10-02 54,421 $15.49 546,490 No 4 M Direct
Common Stock Disposition 2015-10-02 134,090 $28.01 412,400 No 4 S Direct
Common Stock Acquisiton 2015-10-05 910 $15.49 413,310 No 4 M Direct
Common Stock Disposition 2015-10-05 910 $30.10 412,400 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2015-10-02 8,811 $0.00 8,811 $6.00
Common Stock Employee Stock Option (right to buy) Disposition 2015-10-02 70,358 $0.00 70,358 $5.85
Common Stock Employee Stock Option (right to buy) Disposition 2015-10-02 500 $0.00 500 $8.50
Common Stock Employee Stock Option (right to buy) Disposition 2015-10-02 54,421 $0.00 54,421 $15.49
Common Stock Employee Stock Option (right to buy) Disposition 2015-10-05 910 $0.00 910 $15.49
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
4,005 2016-02-15 No 4 M Direct
14,642 2016-03-17 No 4 M Direct
0 2016-09-25 No 4 M Direct
51,673 2016-12-21 No 4 M Direct
50,763 2016-12-21 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 100,000 Indirect Beneficial Ownership in Trust
Footnotes
  1. Exercises and sales pursuant to a 10b5-1 plan. All of the exercised options were scheduled to expire in 2016 on the expiration dates reported within Table II unless exercised. The reporting person sold the shares resulting from the option exercises with the intent to use the proceeds from those sales primarily to cover the exercise prices of the exercised options as well as to fund tax obligations resulting from the reported transactions and other transactions relating to issuer common stock awards granted to the reporting person.
  2. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $28.00 to $28.14 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  3. These shares were previously reported as directly beneficially owned by the reporting person. On May 28, 2015, the reporting person contributed these shares to a grantor retained annuity trust established by the reporting person. The reporting person is the sole trustee of the grantor retained annuity trust.
  4. The shares subject to these options vested in installments and were fully vested on 2/15/2010.
  5. The shares subject to these options vested in installments and were fully vested on 11/10/2010.
  6. The shares subject to these options vested in installments and were fully vested on 9/25/2010.
  7. The shares subject to these options vested in installments and were fully vested on 1/1/2011.